Scientists map muscle decline in rare disease to pave way for future treatments
NCT ID NCT06390566
Summary
This study aims to understand how limb-girdle muscular dystrophy type 2A (LGMD2A) progresses over two years. Researchers will closely monitor 25 patients to measure changes in their muscle strength, movement abilities, and quality of life. The goal is to gather detailed information to help design better future treatment trials, as there is currently no cure for this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIMB GIRDLE MUSCULAR DYSTROPHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Henri Mondor
Créteil, Île-de-France Region, 94130, France
Conditions
Explore the condition pages connected to this study.